ABE Capital and Columbus Venture Partners have reached an agreement to acquire a majority stake in Sermes CRO, a Spanish contract research organization specializing in end-to-end management of clinica...
Read moreThe AI revolution in Pharmaceutical R&D is transitioning from experimental curiosity to operational necessity. This transformation is supported by quantifiable operational improvements: AI-enabled dis...
Read moreUnderstanding the responsibilities involved in Drug Substance and Drug Product manufacturing is essential for making the right strategic decisions. Many biotech companies approaching clinical phases d...
Read moreA multi‑country oncology study regained momentum through structured transition planning, seamless cross‑functional collaboration and decisive operational oversight, regulatory recovery, and discip...
Read more3PBIOVIAN provides end-to-end CDMO services for animal health, supporting the development and GMP manufacturing of veterinary vaccines and biologics. With proven expertise in recombinant proteins, vir...
Read moreEffective scale up in manufacturing requires building predictive understanding, not just replicating conditions. At 53Biologics, their Process Development Services focus on identifying scale-dependent...
Read moreBiotechnology company 53Biologics, specialized in the development and manufacturing of biologic drugs, has announced the closing of a strategic funding round led by European private equity firm Ren Li...
Read moreLa selección de centros en oncología es uno de los factores que más influye a la hora de acortar los tiempos de un ensayo clínico. Por ello, elegir bien dónde abrir un ensayo es casi tan crítico...
Read moreMost biotech teams assume GMP readiness begins when a product enters clinical phases. In reality, the foundations of GMP are built much earlier, during drug development, often without being explicitly...
Read moreLas crisis no deben paralizar la investigación, pero tampoco justificar atajos que pongan en riesgo a los participantes o la validez de los resultados. Este es el leit motiv de la nueva guía de la E...
Read moreCurapath has partnered with Nacalai Tesque to expand access to its portfolio of next-generation polymers and PEG-free shielding lipids for advanced drug delivery applications in Japan.
Read moreHow sponsors can leverage both the EU Clinical Trials Regulation and UK’s reformed framework to achieve cost efficiencies, faster timelines, and stronger regulatory positioning.
Read more